share_log

Karyopharm Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(3.7%),Avidity Partners Management (GP) LLC(3.7%), etc.

Karyopharm Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Avidity Partners Management LP(3.7%),Avidity Partners Management (GP) LLC(3.7%)等

美股SEC公告 ·  11/15 05:27
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息